Does TOBRAMYCIN Cause Nephrolithiasis? 54 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 54 reports of Nephrolithiasis have been filed in association with TOBRAMYCIN (TOBRAMYCIN). This represents 0.5% of all adverse event reports for TOBRAMYCIN.
54
Reports of Nephrolithiasis with TOBRAMYCIN
0.5%
of all TOBRAMYCIN reports
0
Deaths
39
Hospitalizations
How Dangerous Is Nephrolithiasis From TOBRAMYCIN?
Of the 54 reports, 39 (72.2%) required hospitalization.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOBRAMYCIN. However, 54 reports have been filed with the FAERS database.
What Other Side Effects Does TOBRAMYCIN Cause?
Off label use (1,467)
Death (888)
Cough (738)
Dyspnoea (706)
Pneumonia (700)
Hospitalisation (688)
Condition aggravated (669)
Cystic fibrosis (646)
Infective pulmonary exacerbation of cystic fibrosis (504)
Drug ineffective (453)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which TOBRAMYCIN Alternatives Have Lower Nephrolithiasis Risk?
TOBRAMYCIN vs TOBRAMYCIN\TOBRAMYCIN
TOBRAMYCIN vs TOCILIZUMAB
TOBRAMYCIN vs TOCILIZUMAB-AAZG
TOBRAMYCIN vs TOCOPHEROL
TOBRAMYCIN vs TOFACITINIB